03-13
Recently, the "Digital Grid" Platform, developed by State Grid Information & Communication Industry Group Co., Ltd. (SGICT), achieved China's first online precise calculation of theoretical line losses across full voltage classes through multi-source data fusion at municipal level, marking a new stage in intelligent line loss management for China's power grid.03-12
BARCELONA,Spain,March 11,2025-- During MWC 2025,Huawei launched the upgraded FTTO 2.0 solution,leading the development of 10G campus networks.03-12
SHENZHEN,China,March 11,2025-- A news report from 6300: In the digital age,the exponential growth of data has intensified the demand for efficient computing across various fields. TheCUDA-accelerated03-12
BOSTON,March 11,2025-- TraceLink,the largest end-to-end digital network platform for intelligent orchestration of the supply chain,has been recognized by CIOReview as a Top Supply Chain Solution Prov03-12
TOKYO,March 11,2025-- Nellify,Japan\'s premier luxury mattress brand owned by Morght Co.,Ltd.,is now available in the United States,offering an unparalleled sleep experience crafted with Japanese prec03-12
NEW YORK,March 12,2025--The United Nations Global Compact,in partnership with UN Women and the Champions of Change Coalition,today concluded a high-level Business Leadership Dialogue,convened on the03-12
With the power of GameAbove Sports,Bruton,a long-time Australia basketball ambassador,can expand his successful Bruton Basketball Foundation.03-12
WENZHOU,China,March 12,2025-- The 31st South China International Exhibition on Printing Industry took place from March 4 to 6,2025,at the China Import and Export FairPazhou Complex (Area A) in Guangzh03-11
SHENZHEN,China,March 10,2025-- At the Huawei Product & Solution Launch duringMWC Barcelona 2025,Cao Ming,Vice President of Huawei and President of Huawei Wireless Solution,launched AI-Centric 5.5G03-11
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar